EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Unveiling Hope: Progress and Challenges in Rare Disease Drug Development

    Rare diseases often referred to as orphan diseases affect a small percentage of the population Despite their rarity these diseases collectively impact millions of people worldwide The development of drugs

    Harnessing the Intracellular Machinery to Degrade Cellular Proteins

    A countless number of proteins including growth factors receptors and cytokines play a pivotal role during the onset and exacerbation of numerous human diseases including cancer autoimmune and inflammatory disorders Of these proteins extracellular and membraneassociated proteins represent around of human proteome

    Revolutionizing Healthcare with Innovative Therapeutics

    Revolutionizing healthcare with innovative therapeutics involves the development and application of groundbreaking treatments and approaches that significantly improve patient outcomes reduce costs and enhance overall healthcare effectiveness

    mRNA and Oligonucleotide Therapeutics: Emerging Synergies in Genetic Medicine

    MRNA therapies work by introducing synthetic mRNA encoding a therapeutic protein enabling transient protein expression that can replace deficient enzymes stimulate immune responses or facilitate gene editing This additive approach is beneficial for diseases caused by lossoffunction mutations or when temporary protein expression is desired

    Key Stages in Pharmaceutical Formulation Development: A Complete Guide

    One of the most significant operations in the field of drug study is pharmaceutical formulation development to ensure that the medications are distributed to the patients without harm and in the most appropriate manner This is a science that involves the transformation of an active pharmaceutical ingredient API into a solid efficient and convenient dosage form To researchers manufacturers and regu...

    What is Clinical Drug Trials and what are the four phases of clinical trials

    In a clinical trial actors admit specific interventions according to the exploration plan or protocol created by the investigators These interventions may be medical products similar as medicines or bias procedures or changes to actors geste similar as diet Clinical trials may compare a new medical approach to a standard bone thats formerly available to a placebo that contains

TOP ARTICLES

  • 2

    Revolutionizing Healthcare with Innovative Therapeutics

    Kate Williamson

    Revolutionizing healthcare demands innovative therapeutics, including precision medicine, immunotherapy, gene therapy, nanomedicine, telemedicine, AI in drug discovery, regenerative medicine, digital...

press releases Read more...

Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution

Mission Bio a leader in singlecell multiomics today announced Tapestri Triomics a new expansion of the Tapestri Platform that simultaneously analyzes DNA RNA and protein in the same cell By connecting genotype

Phanes Therapeutics announces US patent granted to its proprietary bispecific antibody technology platform PACbody®

Phanes Therapeutics Inc Phanes a clinicalstage biotech company focused on innovative drug discovery and development in immunooncology IO announced today that the US Patent and Trademark Office

DifGen Pharmaceuticals LLC Announces U.S. FDA Approval of Epinephrine Injection USP, 1 mg/mL, Single-Dose Vials

DifGen Pharmaceuticals LLC DifGen a US based specialty generic pharmaceutical company today announced that the US Food and Drug Administration FDA approved its Abbreviated New Drug Application

Upperton granted MHRA licence for Annex 1 aligned sterile manufacturing facility.

Upperton a UKbased contract development and manufacturing organisation CDMO today announced that the Medicines and Healthcare products Regulatory Agency MHRA has approved a variation

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

30 - 01

Sep 2026

Pharma Launch Excellence Summit

Hyatt Regency Boston Harbor, B...

LATEST NEWS Read more...

Novo Nordisk and Anthropic collaborate to advance AI-led drug discovery

Novo Nordisk and Anthropic have announced a collaboration to accelerate drug discovery and development using artificial intelligence AI while also expanding AIsupported software development at Novo

Twist Bioscience joins Lilly TuneLab to support antibody drug discover

Twist Bioscience has entered into an agreement with Lilly TuneLab an artificial intelligence and machine learning AIML drug discovery platform developed by Eli Lilly and Company

Ori Biotech announces $120 million, ten-year partnership for automated cell therapy manufacturing

Ori Biotech Ori a cell and gene therapy manufacturing technology company has announced a tenyear strategic collaboration with a biopharmaceutical company to integrate its IRO platform into a commercial cell therapy manufacturing process

Mighty Therapeutics partners with POLG Foundation to develop preclinical model for mitochondrial disorders and Parkinson’s disease

Mighty Therapeutics a commercialstage biotechnology company developing medicines targeting mitochondrial dysfunction has started a research collaboration with The POLG Foundation Dr Carolyn Sue

Axiom Biosciences partners with GeneFab to expand manufacturing and clinical development capabilities

Axiom Biosciences a clinicalstage biotechnology company developing regenerative therapies and targeted biologics has entered into a strategic partnership with cell and gene therapy contract development and manufacturing organisation CDMO GeneFab

Asimov Partners with Sidewinder Therapeutics on Cell Line Development for Bispecific Antibody

Asimov has entered into a cell line development partnership with Sidewinder Therapeutics to support the development of a fourchain bispecific antibody candidate for solid tumour treatment